Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03044613
Title Nivolumab or Nivolumab/Ipilimumab Prior to Chemoradiation Plus Nivolumab With II/III Gastro/Esophageal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

esophageal cancer

gastroesophageal junction adenocarcinoma

Therapies

Carboplatin + Ipilimumab + Nivolumab + Paclitaxel

Carboplatin + Nivolumab + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.